The diagnostic rate in renal cancer genes was 44.44% (4/9) in syndromic individuals and 2.7% (2/74) in non-syndromic individuals, with pathogenic variants in PTEN and FH in two patients without clinical features of the associated syndromes (Table 5). The gene discussed is FH; the disease is renal carcinoma.